Topical Nonsteroidal Anti-inflammatory Drugs and Cataract Surgery: A Report by the American Academy of Ophthalmology

Ophthalmology

Volumn 122, Issue 11, 2015, Pages 2159-2168

  Kim, Stephen J ^a   Schoenberger, Scott D ^b   Thorne, Jennifer E ^c   Ehlers, Justis P ^d   Yeh, Steven ^e   Bakri, Sophie J ^f   Lum, Flora ^g  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Retina Physicians and Surgeons   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f MAYO CLINIC   (United States)

^g American Academy of Ophthalmology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO;

APHAKIA; ARTICLE; CATARACT; CATARACT EXTRACTION; CORTICOSTEROID THERAPY; DIABETIC PATIENT; DRUG EFFICACY; HUMAN; KERATOPATHY; MEDICAL SOCIETY; META ANALYSIS; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETINA ANGIOGRAPHY; RETINA MACULA CYSTOID EDEMA; SYSTEMATIC REVIEW; TOPICAL TREATMENT; VISUAL IMPAIRMENT; BIOMEDICAL TECHNOLOGY ASSESSMENT; FLUORESCENCE ANGIOGRAPHY; MACULAR EDEMA; OPHTHALMOLOGY; ORGANIZATION; PATHOPHYSIOLOGY; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATION; TOPICAL DRUG ADMINISTRATION; UNITED STATES; VISION DISORDERS;

ACADEMIES AND INSTITUTES; ADMINISTRATION, TOPICAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA; OPHTHALMOLOGY; PHACOEMULSIFICATION; POSTOPERATIVE COMPLICATIONS; TECHNOLOGY ASSESSMENT, BIOMEDICAL; TOMOGRAPHY, OPTICAL COHERENCE; UNITED STATES; VISION DISORDERS;

EID: 84956936695     PISSN: 01616420     EISSN: 15494713     Source Type: Journal    
DOI: 10.1016/j.ophtha.2015.05.014     Document Type: Article

References (40)

1. Kim SJ, Equi R, Bressler NM. Analysis of macular edema after cataract surgery in patients with diabetes using optical coherence tomography. Ophthalmology 2007;114:881-9.
2. Bálair ML, Kim SJ, Thorne JE, et al. Incidence of cystoid macular edema after cataract surgery in patients with and without uveitis using optical coherence tomography. Am J Ophthalmol 2009;148:128-35.
3. Kim SJ, Bressler NM. Optical coherence tomography and cataract surgery. Curr Opin Ophthalmol 2009;20:46-51.
4. Schmier JK, Halpern MT, Covert DW, Matthews GP. Evaluation of costs for cystoid macular edema among patients after cataract surgery. Retina 2007;27:621-8.
5. Miyake K, Ibaraki N. Prostaglandins and cystoid macular edema. Surv Ophthalmol 2002;47(suppl):S203-18.
6. Flach AJ. Topical nonsteroidal antiinflammatory drugs in ophthalmology. Int Ophthalmol Clin 2002;42:1-11.
7. Rossetti L, Chaudhuri J, Dickersin K. Medical prophylaxis and treatment of cystoid macular edema after cataract surgery. The results of a meta-analysis. Ophthalmology 1998;105:397-405.
8. Kim SJ, Flach AJ, Jampol LM. Nonsteroidal anti-inflammatory drugs in ophthalmology. Surv Ophthalmol 2010;55:108-33.
9. Kessel L, Tendal B, Jørgensen KJ, et al. Post-cataract prevention of inflammation and macular edema by steroid and nonsteroidal anti-inflammatory eye drops: a systematic review. Ophthalmology 2014;121:1915-24.
10. Polachek J, Shvartzman P. Acute bronchial asthma associated with the administration of ophthalmic indomethacin. Isr J Med Sci 1996;32:1107-9.
11. Oxford Centre for Evidence-Based Medicine. Levels of Evidence (March 2009). Available at: http://www. cebm. net/index. aspx?o=1025. Accessed November 17, 2014.
12. Miyake K, Sakamura S, Miura H. Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin. Br J Ophthalmol 1980;64:324-8.
13. Yannuzzi LA, Landau AN, Turtz AI. Incidence of aphakic cystoid macular edema with the use of topical indomethacin. Ophthalmology 1981;88:947-54.
14. Flach AJ, Stegman RC, Graham J, Kruger LP. Prophylaxis of aphakic cystoid macular edema without corticosteroids. A paired-comparison, placebo-controlled double-masked study. Ophthalmology 1990;97:1253-8.
15. Kraff MC, Sanders DR, Jampol LM, et al. Prophylaxis of pseudophakic cystoid macular edema with topical indomethacin. Ophthalmology 1982;89:885-90.
16. Solomon LD. Efficacy of topical flurbiprofen and indomethacin in preventing pseudophakic cystoid macular edema. Flurbiprofen-CME Study Group I. J Cataract Refract Surg 1995;21:73-81.
17. Almeida DR, Khan Z, Xing L, et al. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification. J Cataract Refract Surg 2012;38:1537-43.
18. Italian Diclofenac Study Group. Efficacy of diclofenac eyedrops in preventing postoperative inflammation and long-term cystoid macular edema. J Cataract Refract Surg 1997;23:1183-9.
19. Nussenblatt RB, Kaufman SC, Palestine AG, et al. Macular thickening and visual acuity. Measurement in patients with cystoid macular edema. Ophthalmology 1987;94:1134-9.
20. Mentes J, Erakgun T, Afrashi F, Kerci G. Incidence of cystoid macular edema after uncomplicated phacoemulsification. Ophthalmologica 2003;217:408-12.
21. Yavas GF, Oztürk F, Küsbeci T. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema. J Cataract Refract Surg 2007;33:804-7.
22. Miyake K, Ota I, Miyake G, Numaga J. Nepafenac 0. 1% versus fluorometholone 0. 1% for preventing cystoid macular edema after cataract surgery. J Cataract Refract Surg 2011;37:1581-8.
23. Wittpenn JR, Silverstein S, Heier J, et al; Acular LS for Cystoid Macular Edema (ACME) Study Group. A randomized, masked comparison of topical ketorolac 0. 4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol 2008;146:554-60.
24. Wang QW, Yao K, Xu W, et al. Bromfenac sodium 0. 1%, fluorometholone 0. 1% and dexamethasone 0. 1% for control of ocular inflammation and prevention of cystoid macular edema after phacoemulsification. Ophthalmologica 2013;229:187-94.
25. Asano S, Miyake K, Ota I, et al. Reducing angiographic cystoid macular edema and blood-aqueous barrier disruption after small-incision phacoemulsification and foldable intraocular lens implantation: multicenter prospective randomized comparison of topical diclofenac 0. 1% and betamethasone 0. 1%. J Cataract Refract Surg 2008;34:57-63.
26. McGhee CN, Watson DG, Midgley JM, et al. Penetration of synthetic corticosteroids into human aqueous humour. Eye (Lond) 1990;4(Pt 3):526-30.
27. Schoenberger SD, Kim SJ. Nonsteroidal anti-inflammatory drugs for retinal disease. Int J Inflam 2013;2013:281981.
28. Miyake K, Masuda K, Shirato S, et al. Comparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trial. Jpn J Ophthalmol 2000;44:58-67.
29. Donnenfeld ED, Perry HD, Wittpenn JR, et al. Preoperative ketorolac tromethamine 0. 4% in phacoemulsification outcomes: pharmacokinetic-response curve. J Cataract Refract Surg 2006;32:1474-82.
30. Singh R, Alpern L, Jaffe GJ, et al. Evaluation of nepafenac in prevention ofmacular edema following cataract surgery in patients with diabetic retinopathy. Clin Ophthalmol 2012;6:1259-69.
31. Kim SJ, Belair ML, Bressler NM, et al. A method of reporting macular edema after cataract surgery using optical coherence tomography. Retina 2008;28:870-6.
32. Heier JS, Topping TM, Baumann W, et al. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema. Ophthalmology 2000;107:2034-8. discussion 9.
33. O'Brien TP. Emerging guidelines for use of NSAID therapy to optimize cataract surgery patient care. Curr Med Res Opin 2005;21:1131-7.
34. Flach AJ, Kraff MC, Sanders DR, Tanenbaum L. The quantitative effect of 0. 5% ketorolac tromethamine solution and 0. 1% dexamethasone sodium phosphate solution on postsurgical blood-aqueous barrier. Arch Ophthalmol 1988;106:480-3.
35. Zanetti FR, Fulco EA, Chaves FR, et al. Effect of preoperative use of topical prednisolone acetate, ketorolac tromethamine, nepafenac and placebo, on the maintenance of intraoperative mydriasis during cataract surgery: a randomized trial. Indian J Ophthalmol 2012;60:277-81.
36. Simone JN, Pendelton RA, Jenkins JE. Comparison of the efficacy and safety of ketorolac tromethamine 0. 5% and prednisolone acetate 1% after cataract surgery. J Cataract Refract Surg 1999;25:699-704.
37. Morrison E, Archer DB. Effect of fluorometholone (FML) on the intraocular pressure of corticosteroid responders. Br J Ophthalmol 1984;68:581-4.
38. Flynn M, Hebel SK. Drug Facts and Comparison. 51st ed. St. Louis, MO: Lippincott Williams & Wilkins; 1997:122-3.
39. Liu T, Hu AY, Kaines A, et al. A pilot study of normative data for macular thickness and volume measurements using cirrus highdefinition optical coherence tomography. Retina 2011;31: 1944-50.
40. Tzelikis PF, Vieira M, Hida WT, et al. Comparison of ketorolac 0. 4% and nepafenac 0. 1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebocontrolled randomised study. Br J Ophthalmol 2015;99:654-8.